Andy Heller leads Value and Access activities (Payer and Health System customers) for Boehringer’s first prescription digital therapeutic (PDTs) for Mental Health. Andy has returned to Boehringer after working at Pear Therapeutics, where he led Payer/Employer-focused activities for reSET and reSET-O, PDTs for substance use disorder (SUD) and opioid use disorder (OUD), respectively. Part of this work included collaborating with regional business coalitions, to provide awareness and support as it relates to PDTs for SUD and OUD.

Prior to Pear, Andy worked at Boehringer, with a focus on population-health initiatives at large health systems in the U.S.. As part of this, he worked on pilot projects focused on digital therapeutics for COPD. Prior to Boehringer, Andy worked in Market Access consulting for over 10 years.